Mrs Maria Lynn Vosika, MA CCC-SLP | |
455 N Dakota Ave, Corsica, SD 57328-2110 | |
(605) 946-5467 | |
Not Available |
Full Name | Mrs Maria Lynn Vosika |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 455 N Dakota Ave, Corsica, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447715636 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Maria Lynn Vosika, MA CCC-SLP 455 N Dakota Ave, Corsica, SD 57328-2110 Ph: () - | Mrs Maria Lynn Vosika, MA CCC-SLP 455 N Dakota Ave, Corsica, SD 57328-2110 Ph: (605) 946-5467 |
News Archive
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock (the "Series 6 Financing"). The offering is scheduled to close on or about July 27, 2010, subject to the satisfaction of customary closing conditions.
For more than a decade, there has been a focus on involving primary care providers in the follow-up care of cancer survivors.
A promising method for promoting programmed cell death (apoptosis) developed by researchers at the Hebrew University of Jerusalem and the Weizmann Institute of Science paves the way for a possible novel therapy to target cancer cells.
Although mutations in a gene dubbed "the guardian of the genome" are widely recognized as being associated with more aggressive forms of cancer, researchers at the University of California, San Diego School of Medicine have found evidence suggesting that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities, at least in squamous cell head and neck cancers.
› Verified 4 days ago
Natalie Wright, MA CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 39168 269th St, Corsica, SD 57328 Phone: 605-933-1817 |